Colon cancer breakthrough could lead to prevention - and the foods that can help

Colon cancer, Crohn's, and other diseases of the gut could be better treated - or even prevented - thanks to a new link between inflammation and a common cellular process, established by the University of Warwick. Led by Dr Ioannis Nezis at Warwick's School of Life Sciences, new research demonstrates that autophagy - an essential process whereby cells break down and recycle harmful or damaged elements within themselves to keep our bodies healthy - causes tissue inflammation when dysfunctional, which in turn leaves us susceptible to harmful diseases, particularly in the gut.

Understanding this link could lead to more effective treatments for gut diseases - such as colon cancer, irritable bowel syndrome, Crohn's disease and ulcerative colitis - giving healthcare professionals the ability to target the root cause of these diseases, by regulating and controlling autophagy.

Foods such as pomegranates, red grapes, pears, mushrooms, lentils, soybeans and green peas contain natural compounds which can activate autophagy, helping to prevent inflammation and gut diseases.

In a new paper published in Nature Communications, Dr Nezis and colleagues have identified - for the first time - a protein which is regulated by autophagy. Called Kenny, the protein contains a motif of amino acids that causes itself to be broken down by autophagy. When autophagy is dysfunctional, Kenny accumulates and causes inflammation.

The researchers identified this phenomenon in fruit flies, by turning Kenny fluorescent - so it would be visible - and observing at a microscopic level that the protein was present in the cell where autophagy was occurring.

They also noted that dysfunctional autophagy causes serious inflammation in fruit flies - particularly in the gut - which makes tissue inflamed, causing disease, and making the lifespan of a fruit fly half that of other flies.

To prevent serious diseases of the gut caused by inflammation, Dr Nezis and his colleagues state that it is necessary to find ways to control and regulate autophagy.

Humans are in even more danger from the link between autophagy, inflammation, and a dysfunctional or diseased gut - because our bodies lack the regular motif of amino acids which Kenny uses in fruit flies, making its breakdown by autophagy difficult to control or regulate.

Dr Ioannis Nezis, the lead author of the research, commented: "Understanding the molecular mechanisms of selective autophagy and inflammation will help to use interventions to activate the autophagic pathway to prevent inflammation and promote healthy well-being during the life course.

"Natural compounds contained in fruits and vegetables like pomegranates, red grapes, pears, mushrooms, lentils, soybeans and green peas have been shown to activate autophagy, therefore inclusion of the above in our diet would help to prevent inflammation and alleviate the symptoms of gut diseases."

Tusco R, Jacomin AC, Jain A, Penman BS, Larsen KB, Johansen T, Nezis IP.
Kenny mediates selective autophagic degradation of the IKK complex to control innate immune responses.
Nat Commun. 2017 Nov 2;8(1):1264. doi: 10.1038/s41467-017-01287-9.

Most Popular Now

Top 20 breaking World Pharma News of 2017

We are proud to announce the top 20 most popular breaking World Pharma News from 2017. Have a wonderful 2018 new(s) year filled with health, happiness, and spectacular su...

Roche and Ignyta reach definitive merger agreement

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. (NASDAQ: RXDX) today announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta ...

Antidepressant may help combat the course of multi…

The antidepressant clomipramine may also alleviate symptoms of multiple sclerosis (MS), specifically in its progressive form, i.e. when it occurs without relapses or remi...

Novartis advances head-to-head superiority trials …

Novartis announced today the initiation of SURPASS, a head-to-head clinical trial of Cosentyx® (secukinumab) versus proposed biosimilar adalimumab** in ankylosing spondyl...

Distinct human mutations can alter the effect of m…

Every person has a unique DNA sequence in their genome. Now researchers from the University of Copenhagen and the MRC Laboratory of Molecular Biology in Cambridge have tr...

FDA updates the label of Tasigna to reflect that c…

The U.S. Food and Drug Administration today updated the product label for the cancer drug Tasigna (nilotonib) to include information for providers about how to discontinu...

Researchers repurpose immune-activating cytokine t…

The most lethal form of breast cancer could have a new treatment option, according to new research out of the Case Comprehensive Cancer Center at Case Western Reserve Uni...

Zika remains a research and public health challeng…

Since 2016, when Zika was declared by the World Health Organization as a public health emergency of international concern, the virus has become established in more than 8...

FDA approves novel gene therapy to treat patients …

The U.S. Food and Drug Administration today approved Luxturna (voretigene neparvovec-rzyl), a new gene therapy, to treat children and adult patients with an inherited for...

Diabetes drug 'significantly reverses memory loss…

A drug developed for diabetes could be used to treat Alzheimer's after scientists found it "significantly reversed memory loss" in mice through a triple method of action...

Try exercise to improve memory, thinking

For patients with mild cognitive impairment, don't be surprised if your health care provider prescribes exercise rather than medication. A new guideline for medical pract...

US FDA accepts regulatory submission for Tagrisso …

AstraZeneca today announced that the US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application (sNDA) for the use of Tagrisso (osimertinib), ...

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]